Programmed death-ligand 1 tumor proportion score in predicting the safety and efficacy of PD-1/PD-L1 antibody-based therapy in patients with advanced non-small cell lung cancer: A retrospective, multicenter, observational study

Yuequan Shi, Mengzhao Wang, Jian Fang et al.|Chinese Medical Journal|2025

Cited by 1